Objective
To generate income and achieve capital growth, whilst seeking to maintain lower levels of portfolio volatility than traditional equity portfolios by adopting a multi-asset strategy.
Management group
J.P. Morgan Asset Management
Launch date
02/03/2018
Next AGM date
08/07/2022
Domicile
United Kingdom
Fund manager
Katy Thorneycroft, Gareth Witcomb
Dividend frequency
Quarterly
Wind-up provisions
In accordance with the Articles, the Directors are required to propose an ordinary resolution that the Company continues its business as a closed-ended investment company at the fifth AGM of the Company expected to be held in 2023. If the Continuation Vote is passed by a simple majority, the Directors are required to put a further Continuation Vote to Shareholders at the AGM of the Company every fifth year thereafter.
Total assets (m) Market Cap (m) Price (last close) NAV Dividend dates Discount / premium (%) Gearing (%) Dividend yield (%) Ongoing charge (%)
80.03 79.00 99.50 100.80 Mar, Jun, Sep, Dec -1.29 0 4.12 1.07 (28/02/2022)
Scroll

Dividends

Dividends declared in last 12 months

Ex-Dividend date Payment date Dividend amount Dividend type Special dividend Financial year
31/03/2022 06/05/2022 1.025 Income No 2022
23/12/2021 04/02/2022 1.025 Income No 2022
30/09/2021 05/11/2021 1.025 Income No 2022
01/07/2021 06/08/2021 1.025 Income No 2022
Scroll

Performance (%)

Return type 1 year 3 years 5 years 10 years
JPMorgan Multi-Asset Growth & Income Share price total return 1.9 21.6 N/A N/A
Flexible Investment AIC sector Share price total return 4.9 14.7 26.1 126.0
Scroll

Share structure

Number of shares
79,393,408

Traded volumes (number of shares)

  Yesterday 1 month 1 year 5 years
Total 18,609 1,726,606 17,291,872 0
Average N/A 82,219 68,347 0
Scroll

Traded values (m)

  Yesterday 1 month 1 year 5 years
Total 0.02 1.75 18.08 0
Average N/A 0.08 0.07 0
Scroll

Trading details

ISIN TIDM Traded currency Stock exchange
GB00BFWJJT14 MATE GBX London Stock Exchange - MAIN
Scroll

Top holdings

Data as at : 31/03/2022

Investment % of total assets
Johnson & Johnson 5.1
Coca-Cola 4.0
AbbVie 4.0
Procter & Gamble 3.7
Roche 3.5
Bristol-Myers Squibb 3.1
McDonalds 2.8
Texas Instruments 2.8
Nestle 2.6
Merck & Co 2.4

Morningstar logo Data provided by Morningstar.

FE fundinfo logo Company documents provided by FE fundinfo.